Dec 23 (Reuters) - DiagnoCure Inc CUR.TO :
* Press release - Diagnocure announces the execution of an asset purchase
agreement
* Says transaction to include selling assets associated with pca3 to Hologic
Inc,
* Transaction to include repurchase of preferred shares held by gen-probe
incorporated
* Deal for C$6.5 million
* Says gen-probe has agreed to acquire all assets related to diagnocure's pca3
prostate cancer biomarker for CAD$6.5 million
* Says corporation will distribute following closing of transaction
approximately 95% of proceeds received to shareholders
* Source text for Eikon ID:nPnVwYdL
* Further company coverage CUR.TO